Carboxypeptidase A1 (Pancreatic) (CPA1) Peptide
CPA1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all CPA1 products
- CPA1 (Carboxypeptidase A1 (Pancreatic) (CPA1))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CPA1 antibody (Catalog #: ARP33859_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CPA1 (Carboxypeptidase A1 (Pancreatic) (CPA1))
- Background
-
Three different forms of human pancreatic procarboxypeptidase A have been isolated. The A1 and A2 forms are monomeric proteins with different biochemical properties. Carboxypeptidase A1 is a monomeric pancreatic exopeptidase. It is involved in zymogen inhibition.
Alias Symbols: CPA
Protein Size: 419 - Molecular Weight
- 47 kDa
- Gene ID
- 1357
- NCBI Accession
- NM_001868, NP_001859
- UniProt
- P15085
-
You are here:
